Vir Biotechnology Inc
NASDAQ:VIR

Watchlist Manager
Vir Biotechnology Inc Logo
Vir Biotechnology Inc
NASDAQ:VIR
Watchlist
Price: 5.09 USD -3.42% Market Closed
Market Cap: 702.7m USD

Intrinsic Value

VIR's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one VIR stock under the Base Case scenario is 1.72 USD. Compared to the current market price of 5.09 USD, Vir Biotechnology Inc is Overvalued by 66%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

VIR Intrinsic Value
1.72 USD
Overvaluation 66%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Vir Biotechnology Inc

Valuation History Unavailable

Historical valuation for VIR cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare VIR to

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about VIR?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Vir Biotechnology Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Vir Biotechnology Inc

Current Assets 932.2m
Cash & Short-Term Investments 801.7m
Other Current Assets 130.5m
Non-Current Assets 375.5m
Long-Term Investments 218.1m
PP&E 120.2m
Intangibles 25m
Other Non-Current Assets 12.1m
Efficiency

Free Cash Flow Analysis
Vir Biotechnology Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Vir Biotechnology Inc

Revenue
20.9m USD
Cost of Revenue
-786k USD
Gross Profit
20.1m USD
Operating Expenses
-631.7m USD
Operating Income
-611.6m USD
Other Expenses
33.9m USD
Net Income
-577.6m USD
Fundamental Scores

VIR Profitability Score
Profitability Due Diligence

Vir Biotechnology Inc's profitability score is 16/100. The higher the profitability score, the more profitable the company is.

16/100
Profitability
Score

Vir Biotechnology Inc's profitability score is 16/100. The higher the profitability score, the more profitable the company is.

VIR Solvency Score
Solvency Due Diligence

Vir Biotechnology Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
61/100
Solvency
Score

Vir Biotechnology Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VIR Price Targets Summary
Vir Biotechnology Inc

Wall Street analysts forecast VIR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VIR is 18.8 USD with a low forecast of 12.12 USD and a high forecast of 32.55 USD.

Lowest
Price Target
12.12 USD
138% Upside
Average
Price Target
18.8 USD
269% Upside
Highest
Price Target
32.55 USD
539% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Vir Biotechnology Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for VIR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

VIR Insider Trading
Buy and sell transactions by insiders

VIR News

Other Videos
What is the Intrinsic Value of one VIR stock?

The intrinsic value of one VIR stock under the Base Case scenario is 1.72 USD.

Is VIR stock undervalued or overvalued?

Compared to the current market price of 5.09 USD, Vir Biotechnology Inc is Overvalued by 66%.

Back to Top